We demonstrated that both Bax and p53 are up-regulated in these cells and that the Bax/Bcl2 ratio increases, suggesting that Bax and Bcl2 may be involved in the mechanism of CBD-mediated cell death in prostate cancer cells. The gene discussed is BCL2; the disease is prostate carcinoma.